Caxton Associates (New York)’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $854K | Sell |
2,844
-1,444
| -34% | -$433K | 0.03% | 242 |
|
2024
Q3 | $1.74M | Buy |
+4,288
| New | +$1.74M | 0.07% | 149 |
|
2024
Q2 | – | Sell |
-2,052
| Closed | -$684K | – | 526 |
|
2024
Q1 | $684K | Sell |
2,052
-1,983
| -49% | -$661K | 0.04% | 280 |
|
2023
Q4 | $1.09M | Sell |
4,035
-1,853
| -31% | -$502K | 0.06% | 213 |
|
2023
Q3 | $1.45M | Buy |
+5,888
| New | +$1.45M | 0.2% | 88 |
|
2022
Q3 | – | Sell |
-10,362
| Closed | -$1.74M | – | 542 |
|
2022
Q2 | $1.74M | Buy |
+10,362
| New | +$1.74M | 0.17% | 38 |
|
2021
Q4 | – | Sell |
-1,273
| Closed | -$309K | – | 578 |
|
2021
Q3 | $309K | Buy |
+1,273
| New | +$309K | 0.03% | 283 |
|
2020
Q3 | – | Sell |
-2,321
| Closed | -$225K | – | 389 |
|
2020
Q2 | $225K | Buy |
+2,321
| New | +$225K | 0.02% | 333 |
|
2019
Q4 | – | Sell |
-5,264
| Closed | -$634K | – | 443 |
|
2019
Q3 | $634K | Buy |
+5,264
| New | +$634K | 0.13% | 93 |
|
2019
Q2 | – | Sell |
-2,564
| Closed | -$334K | – | 447 |
|
2019
Q1 | $334K | Buy |
+2,564
| New | +$334K | 0.05% | 217 |
|
2015
Q2 | – | Sell |
-15,000
| Closed | -$1.13M | – | 151 |
|
2015
Q1 | $1.13M | Buy |
+15,000
| New | +$1.13M | 0.05% | 106 |
|
2014
Q4 | – | Sell |
-25,000
| Closed | -$1.76M | – | 133 |
|
2014
Q3 | $1.76M | Sell |
25,000
-75,000
| -75% | -$5.29M | 0.06% | 122 |
|
2014
Q2 | $5.64M | Buy |
100,000
+10,000
| +11% | +$564K | 0.29% | 48 |
|
2014
Q1 | $4.73M | Sell |
90,000
-810,000
| -90% | -$42.5M | 0.29% | 52 |
|
2013
Q4 | $42.9M | Buy |
+900,000
| New | +$42.9M | 1.36% | 11 |
|
2013
Q3 | – | Hold |
0
| – | – | – | 173 |
|